X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (63) 63
gadolinium (51) 51
radiology, nuclear medicine & medical imaging (45) 45
humans (42) 42
gbca (39) 39
nephrogenic systemic fibrosis (34) 34
magnetic resonance imaging (31) 31
male (23) 23
contrast agents (22) 22
contrast media (21) 21
female (19) 19
dentate nucleus (18) 18
gadolinium-based contrast agents (18) 18
mri (18) 18
contrast media - adverse effects (17) 17
middle aged (17) 17
globus-pallidus (15) 15
gadolinium - adverse effects (13) 13
gadolinium-based contrast agent (13) 13
adult (12) 12
contrast media - pharmacokinetics (11) 11
pharmacokinetics (11) 11
aged (10) 10
article (10) 10
brain (10) 10
contrast media - administration & dosage (10) 10
gadodiamide (10) 10
image enhancement - methods (10) 10
radiology (10) 10
safety (10) 10
t1-weighted mr-images (10) 10
animals (9) 9
gadolinium - pharmacokinetics (9) 9
gbcas (9) 9
magnetic resonance imaging - methods (9) 9
contrast media - metabolism (8) 8
deposition (8) 8
gadobenate dimeglumine (8) 8
high-signal intensity (8) 8
plasma-mass spectroscopy (8) 8
stability (8) 8
blood (7) 7
high signal intensity (7) 7
human bone tissue (7) 7
normal renal-function (7) 7
rats (7) 7
retention (7) 7
adolescent (6) 6
aged, 80 and over (6) 6
contrast agent (6) 6
fibrosis (6) 6
gadobutrol (6) 6
gadopentetate dimeglumine (6) 6
health aspects (6) 6
mass spectrometry (6) 6
medicine & public health (6) 6
toxicity (6) 6
analysis (5) 5
brain - metabolism (5) 5
gadolinium - administration & dosage (5) 5
gadolinium deposition (5) 5
gadoterate meglumine (5) 5
imaging / radiology (5) 5
kontrastmittel (5) 5
liver (5) 5
magnetic resonance (5) 5
mri contrast agents (5) 5
nephrogenic fibrosing dermopathy - chemically induced (5) 5
organometallic compounds - pharmacokinetics (5) 5
original (5) 5
rats, wistar (5) 5
relaxivity (5) 5
reproducibility of results (5) 5
brain - drug effects (4) 4
dermopathy (4) 4
dimeglumine (4) 4
gadolinium - metabolism (4) 4
gadolinium based contrast agents (4) 4
gd-eob-dtpa (4) 4
hyperintense dentate nucleus (4) 4
image enhancement (4) 4
in-vivo (4) 4
kidneys (4) 4
magnetic resonance imaging - adverse effects (4) 4
media (4) 4
nephrogenic fibrosing dermopathy - pathology (4) 4
neuroradiology (4) 4
nsf (4) 4
nuclear magnetic resonance--nmr (4) 4
organometallic compounds - adverse effects (4) 4
prospective studies (4) 4
quantification (4) 4
research (4) 4
retrospective studies (4) 4
risk factors (4) 4
sensitivity and specificity (4) 4
treatment outcome (4) 4
usage (4) 4
abridged index medicus (3) 3
biodistribution (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigative Radiology, ISSN 0020-9996, 08/2009, Volume 44, Issue 8, pp. 433 - 439
Journal Article
Journal Article
Journal Article
Procedia Engineering, ISSN 1877-7058, 2017, Volume 180, pp. 1763 - 1772
Waste management in commercial buildings is a critical factor in urban sustainability and is an important element in achieving green building certification.... 
Waste management | collaborative design process | GBCA | commercial buildings | green building | Green Star Office accreditation
Journal Article
Current Radiology Reports, ISSN 2167-4825, 11/2016, Volume 4, Issue 11, pp. 1 - 7
Gadolinium-based contrast agents (GBCAs) have been used since 1988 for magnetic resonance imaging. These agents were considered very safe and, excluding... 
Gadolinium-based contrast agents (GBCAs) | Medicine & Public Health | Nephrogenic systemic fibrosis (NSF) | Gadolinium toxicity | Imaging / Radiology | Gadolinium deposition | Magnetic resonance (MRI)
Journal Article
Journal Article
Journal Article
South African Journal of Radiology, ISSN 1027-202X, 08/2013, Volume 17, Issue 3, pp. 106 - 107
Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis.... 
Gadolinium | Contrast media | Fibrosis | Contrast agents | Kidneys | Hemodialysis | Pathogenesis | Renal failure | Ligands | Kidney transplantation | NSF | GBCA | Nephrogenic systemic fibrosis | gadolinium-based contrast agents | gadolinium-based contrast media
Journal Article
Multiple Sclerosis Journal – Experimental, Translational and Clinical, ISSN 2055-2173, 1/2019, Volume 5, Issue 1, p. 2055217318823796
Objective The objective of this paper is to evaluate potential dose-dependent adverse effects of gadolinium-based contrast agents (GBCAs) on MS progression.... 
Journal Article
La radiologia medica, ISSN 0033-8362, 6/2015, Volume 120, Issue 6, pp. 557 - 562
Journal Article
Academic Radiology, ISSN 1076-6332, 2012, Volume 19, Issue 10, pp. 1181 - 1185
Journal Article
Journal Article
Proceedings of the 17th International Symposium on Advancement of Construction Management and Real Estate, 2014, pp. 91 - 98
Conference Proceeding
Quantitative Imaging in Medicine and Surgery, ISSN 2223-4292, 9/2012, Volume 2, Issue 3, pp. 147 - 150
A group of experienced researchers in the field of experimental studies investigating the condition nephrogenic systemic fibrosis (NSF) were invited for a... 
Nephrogenic systemic fibrosis (NSF) | chronic kidney disease (CKD) | gadolinium based contrast agents (GBCAs) | Meeting Report
Journal Article
05/2015, ISBN 0470906251, 9
Diagnostic imaging safety has garnered considerable interest in medical literature because of concerns of health risks attributable to imaging investigation.... 
iodine‐based contrast agents (IBCAs) | diagnostic imaging safety | MRI | breast milk | cancer | Gadolinium‐based contrast agents (GBCAs) | ionizing radiation | Iodine-based contrast agents (IBCAs) | Ionizing radiation | Gadolinium-based contrast agents (GBCAs) | Diagnostic imaging safety | Breast milk | Cancer
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.